ページ8 - スペインの最高医師 — オンライン診察を受ける

Dr. Francesc Bosch is an expert in Chronic Lymphocytic Leukemia (CLL) and lymphomas. He leads research in the molecular causes and new treatments for CLL and other lymphoproliferative disorders.

He has published over 100 articles in leading journals, including The New England Journal of Medicine and Nature Medicine. Dr. Bosch oversees more than 80 clinical studies, from phase 1 to phase 3, and plays a key role in developing new drugs.

He is the Head of Hematology at Vall d’Hebron University Hospital and IOB Institute of Oncology. He also serves as president of GELLC and is a professor of hematology. His work has improved diagnosis and treatment for blood diseases.

Dr. Ana Oaknin is a Medical Oncologist with expertise in angiogenesis, DNA repair, and immunology. She focuses on gynecological cancers. Dr. Oaknin earned her medical degree and MD in Medical Oncology from Complutense University of Madrid. She also holds a PhD from Universidad Autonoma de Barcelona.

Dr. Oaknin is Co-Chair of the GEICO Group. She is a faculty member for the Gyn-Track in the European Society of Medical Oncology. She represents Spain in the GOG and GCIG committees. Dr. Oaknin is an active member of ASCO, ESMO, and SEOM. She has published over 100 scientific articles and presentations. She also leads several clinical trials in ovarian, cervical, and endometrial cancer.

Dr. Jesus Soberino is an oncologist at Vall d’Hebron University Hospital and the Vall d’Hebron Institute of Oncology (VHIO). He specializes in breast cancer and melanoma. Dr. Soberino has led many phase 1–3 clinical trials. His work has helped approve important drugs, including CDK4/6 inhibitors for metastatic breast cancer and immunotherapies for melanoma.

His areas of expertise include endocrine therapy, managing hormone resistance, and developing new immunotherapies. Dr. Soberino is known for his patient-centered care. He actively collaborates in research to improve cancer treatment. He is accredited by VHIO and is a key member of the Breast Cancer and Melanoma Units.

Dr. Aleix Prat is a clinical scientist with expertise in breast cancer research, gene expression, and clinical trials. He earned his MD from the University of Barcelona. He completed his oncology fellowship at Vall d’Hebron Institute of Oncology. Dr. Prat leads the Translational Genomics and Targeted Therapeutics in Solid Tumors Group at IDIBAPS. He is also President of SOLTI and serves on the Executive Committee of The Breast International Group.

Dr. Prat has published over 160 scientific papers. His work has received 13,479 citations, and he has an H-Index of 51. He is a Tenure-Track Professor at the University of Barcelona. He also directs the Breast Pathology–Senology Master’s degree. His roles highlight his strong academic and clinical contributions to oncology.

Dr. Francesc Graus is a neurologist with expertise in paraneoplastic neurological syndromes, gliomas, and primary brain lymphomas. He established the first strict diagnostic criteria for paraneoplastic syndromes. He also identified important antibodies that are now used in diagnosis. His research showed the link between tumors and autoimmune neurological attacks.

Dr. Graus earned his MD and PhD from Universitat Autònoma de Barcelona. He completed his neurology residency in Barcelona and a neuro-oncology fellowship at Memorial Sloan-Kettering Cancer Center. He is an Emeritus investigator at IDIBAPS. He founded and served as president of the European Association of Neuro-Oncology. He is also the former chief of neurology at Hospital Clinic Barcelona.

Dr. Fernando Azpiroz Vidaur is a highly experienced gastroenterologist with over 35 years of experience in gastrointestinal research, gut disorders, gut motility, visceral sensitivity, and intestinal gas dynamics. He has received medical degrees from the University of Valladolid and San Carlos University Hospital in Madrid, a fellowship from Mayo Clinic's Gastrointestinal Research Unit, and numerous awards for his clinical research. He is also the President of the European Society of Neurogastroenterology and Motility and a Councilor of the International Motility Group.

One of the world-renowned pioneers in gastrointestinal surgery. Has developed new techniques for the colon and rectum cancer treatment TaTMEТ and NOTES — applied now around the world.
Has performed over 15,000 surgeries.
Performs over 1,000 interventions a year using minimally invasive techniques.
President of the Association of Surgeons-Endoscopists in Europe.

Dr. Jose Hinojosa Mena-Bernal is a Spanish pediatric neurosurgeon. He specializes in neuro-oncology, neuroendoscopy, maxillofacial, and minimally invasive surgery. He leads the Neurosurgery Department at Sant Joan De Déu Children’s Hospital. Dr. Hinojosa has also held leadership positions at other major hospitals in Spain.

He has written 93 scientific papers. Dr. Hinojosa works as an editor and reviewer for leading neurosurgical journals. He is President of the Spanish Society of Pediatric Neurosurgery. He is also an active member of international groups such as ISPN and EANS. His roles show his strong reputation and influence in pediatric neurosurgery.

Dr. Marta Morales Ballús is a pediatric ophthalmologist with over 20 years of experience in treating patients with congenital cataracts and performing pediatric anterior segment surgery. She holds a degree in general medicine and surgery from Barcelona University and is a member of the Catalan Society of Ophthalmology, the Spanish Strabology Society, and the European Paediatric Ophthalmological Society. She is also a teaching specialist at Hospital Sant Joan de Déu Barcelona.

Pediatric orthopedist-traumatologist, specializes in surgical oncology

15 years of experience

• 
  
• He passed specialization in orthopedic surgery and traumatology at the Children's Research Hospital of St. Jude in Memphis, USA (2007-2008).
• Dr. Thorner Rubins currently teaches at the University of Barcelona.
• Нe is the head of the Department of Orthopedics and Traumatology at the Hospital Sant Joan de Déu in Barcelona.

Dr. Joseba Rebollo Liceaga is a seasoned medical oncologist with a comprehensive background in oncology.​

Education and Training:

Graduated in Medicine and Surgery from the University of Navarra (1985).​

Completed residency in Oncology in 1987.​

Specialist in Medical Oncology at the Clínica Universidad de Navarra (1991).​

Professional Experience:

Head of the Oncology Department at Clínica San Miguel de Navarra (1991–2004).​

Associate Physician at the University Clinic of the Faculty of Medicine, University of Navarra (1995–2002).​

Adjunct Physician at the Oncology Platform, Hospital Quirónsalud Torrevieja (2004–2014).

Head of the Oncology Department at Hospital General de Villalba (2014–2019).​

Currently practices as a Medical Oncology Specialist at Quirónsalud Alicante.​

Certifications and Training:

Completed multiple accredited courses in Multidisciplinary Oncology between 2003 and 2006.​

Research and Publications:

Authored research on electrochemotherapy and multidisciplinary treatment approaches in oncology.

Education and Training

Doctor of Medicine, Cum Laude, University of Navarra (1991)

Medical Degree, University of Navarra (1979–1985), Graduated with Honors

Board-Certified Specialist in Medical Oncology, via Spanish MIR system, Clínica Universidad de Navarra (1986–1989)

Advanced Fellowship in Immunotherapy, Cleveland Clinic Foundation, USA

Professional Experience

Head of Medical Oncology (1993–2000) and Director of the Cancer Institute (2000–2002), General Hospital of Catalonia

Director of Hematopoietic Progenitor Transplant Program, General Hospital of Catalonia (1993–2002), accredited by the Catalonian Health Department

Senior Specialist in Oncology, Quirónsalud Torrevieja (since 2002)

Clinical Innovations & Special Programs

Personalized Cancer Therapy using RNA microarrays and pharmacogenomics

Autologous Bone Marrow Transplants and High-Dose Chemotherapy

High-Dose Interleukin-2 Therapy via intravenous bolus for solid tumors

Personalized Cellular Anti-Tumor Vaccines

Hyperthermic Isolated Limb Perfusion with TNF and melphalan

Intra-arterial and Intraoperative Chemotherapy (HIPEC) for advanced cancers

Research & Academic Contributions

Author of 120+ scientific papers and conference presentations

Active contributor to the development of novel cancer immunotherapies and drug personalization strategies

Memberships

AACR – American Association for Cancer Research

ASCO – American Society of Clinical Oncology

ASH – American Society of Hematology

Specialties

-General and Digestive Surgery

-Laparoscopic Surgery (Minimally Invasive Techniques)

-Surgical Oncology

-HIPEC (Hyperthermic Intraperitoneal Chemotherapy)

-Colorectal, Gastric, and Peritoneal Cancer Surgery

Current Position

Senior Surgeon, Department of General and Digestive Surgery

Hospital Quirónsalud Torrevieja, Spain

Clinical Expertise

Minimally invasive cancer surgery with laparoscopic and robotic techniques

Cytoreductive surgery with HIPEC for peritoneal carcinomatosis

Colorectal cancer, gastric cancer, and complex abdominal surgeries

Multidisciplinary treatment planning for gastrointestinal malignancies

Academic & Research Contributions

Author of numerous peer-reviewed publications and book chapters in surgical oncology

Frequent speaker at international congresses on advanced surgical oncology and HIPEC

Actively involved in clinical research and surgical training programs

Professional Recognition

Widely regarded as a reference in Spain and internationally for HIPEC and advanced laparoscopic cancer surgery

Mentor to upcoming surgeons in the field of minimally invasive oncologic surgery

Research and Publications:

Extensive Scholarly Work: Authored and co-authored over 48 publications focusing on surgical oncology, hepatobiliary surgery, and innovative cancer treatments. His research has garnered over 1,100 citations, reflecting significant contributions to the medical community. ​

Professional Affiliations:

Academic Roles: Serves as an Associate Professor in the Department of Health Sciences at Saint Anthony Catholic University in Murcia, Spain, since January 2014

Education and Training:

Medical Degree: Graduated from Universidad Miguel Hernández de Elche (1993–1999).​

Dermatology Residency: Completed at Hospital General Universitario de Alicante (2000–2004).​

Dermatopathology Fellowships: Undertook specialized training at St John's Institute of Dermatology in London and in Winston-Salem, North Carolina, USA (2003).​

International Certification: Achieved the International Board Certification in Dermatopathology (ICDP-UEMS) in 2007

Advanced Training in Hidradenitis Suppurativa: Completed at Hospital de Roskilde, Copenhagen, Denmark (2015).​

Professional Experience:

Hospital General Universitario de Elche: Served as a dermatologist from 2004 to 2010.​

Hospital General Universitario de Alicante: Practicing dermatologist since 2010.​

Hospital Quirónsalud Torrevieja: Specialist in Dermatology since 2006.​

Quirónsalud Alicante: Specialist in Dermatology.​

Research and Publications:

Authored over 50 national and international scientific publications.​

Regular presenter at various dermatology and dermatopathology conferences.​

Professional Affiliations:

Member of the Spanish Academy of Dermatology and Venereology (AEDV).​

Member of the Spanish Group of Dermatopathology.​

Member of the European Hidradenitis Suppurativa Foundation.​

Member of the International Society of Dermoscopy.​

Dr. Pascual Ramírez's comprehensive training and active involvement in research and professional societies underscore his commitment to advancing dermatological care and education.

Experience

On his return from London, he organized and directed the Arrhythmia Unit of the Cardiology Service of the Nuestra Señora del Pino University Hospital in Las Palmas until the year 2000.

Later he was associate head of the Arrhythmia Unit and Director of the Electrophysiology Laboratory of the Fundación Jiménez Díaz in Madrid.

Professor of Cardiology at the Autonomous University and Fellowship Program Director of the North American Society of Pacing and Electrophysiology (Heart Rhythm Society) positions that he held for 6 years until his transfer to the Quirónsalud Madrid University Hospital in 2006.

Dr. Cabrera has been the head of the Cardiology service at the Quirónsalud Madrid University Hospital since the hospital began operating in 2006.

Since January 2013, he is also head of the Cardiology Unit of the Ruber Juan Bravo Hospital Complex and in 2022 head of service of the new Olympia center.

He is a professor at the European University of Madrid where he directs the Chair of Clinical and Basic Translational Cardiology.

Title

Doctorate in Medicine and Surgery at the Faculty of Medicine of the University of Granada. He completed his post-graduate training as an interventional cardiologist in the Arrhythmia Unit (cardiac Electrophysiology laboratory) of the Fundación Jiménez Díaz in Madrid since 1994 -1996.

Senior Research Fellow. at the National Heart & Lung Institute. Royal Brompton. Paediatric Cardiac Morphology under the direction of Prf. Robert H Anderson in London (UK) during the year 1997.